Inventor
LUNDBECK JANE MARIE
DK23 patents
⚠️ This page may combine multiple inventors who share the name “LUNDBECK JANE MARIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVO NORDISK AS
15 patentsUS6869947B2Mar 22, 2005
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
NOVO NORDISK AS177 citations98
US7192952B2Mar 20, 2007
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
NOVO NORDISK AS115 citations97
US6380398B2Apr 30, 2002
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
NOVO NORDISK AS127 citations97
US6645995B2Nov 11, 2003
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
NOVO NORDISK AS72 citations96
US7235538B2Jun 26, 2007
Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV
NOVO NORDISK AS120 citations95
US7598391B2Oct 6, 2009
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS14 citations92
US6590118B1Jul 8, 2003
Aromatic compounds
NOVO NORDISK AS24 citations92
US5952363ASep 14, 1999
Pyrrolidine compounds useful in the treatment of diabetes
NOVO NORDISK AS25 citations92
US6046214AApr 4, 2000
Heterocyclic compounds
NOVO NORDISK AS43 citations91
US6177443B1Jan 23, 2001
4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
NOVO NORDISK AS45 citations88
USRE45183EOct 7, 2014
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS7 citations83
US7872139B2Jan 18, 2011
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS10 citations83
US7851636B2Dec 14, 2010
Heteroaryl-ureas and their use as glucokinase activators
NOVO NORDISK AS8 citations83
US5834482ANov 10, 1998
Heterocyclic chemistry
NOVO NORDISK AS6 citations61
US6090797AJul 18, 2000
4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
NOVO NORDISK AS4 citations58